COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 1 of 1 for:    NCT03589469
Previous Study | Return to List | Next Study

Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03589469
Recruitment Status : Active, not recruiting
First Posted : July 18, 2018
Last Update Posted : June 17, 2020
Information provided by (Responsible Party):
ADC Therapeutics S.A.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : May 24, 2020
Estimated Study Completion Date : March 18, 2021